SCHEMBL7108637

SCHEMBL7108637

COc1ccc2cc(-c3ccccc3OC)sc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.53
HSP90AA1 P07900 1/20 0.47
CA2 P00918 1/20 0.46
SMN1; SMN2 Q16637 4/20 0.45
MEN1 O00255 3/20 0.45
MAPT P10636 3/20 0.45
RAB9A P51151 3/20 0.45
KMT2A Q03164 3/20 0.45
MAPK1 P28482 2/20 0.45
NPC1 O15118 2/20 0.45
NFKB1 P19838 2/20 0.45
NFKB2 Q00653 2/20 0.45
RELA Q04206 2/20 0.45
MAPK3 P27361 1/20 0.45
MAP2K1 Q02750 1/20 0.45
GFER P55789 1/20 0.45
CYP1A2 P05177 1/20 0.44
CYP2A6 P11509 1/20 0.44
ALDH1A1 P00352 3/20 0.43
HPGD P15428 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21184952 0.85 ESR1 (0.48) CA2SMN1; SMN2MEN1MAPTRAB9A
SCHEMBL5682739 0.85 APP (0.53) APPHSP90AA1SMN1; SMN2MEN1MAPT
SCHEMBL17167476 0.84 APP (0.59) APPSMN1; SMN2MEN1MAPTRAB9A
SCHEMBL5743204 0.83 MAPT (0.52) APPHSP90AA1SMN1; SMN2MAPTRAB9A
SCHEMBL31402836 0.82 CYP1A1 (0.49) SMN1; SMN2MEN1MAPTRAB9AKMT2A
SCHEMBL21735627 0.81 NFKB1 (0.45) APPCA2SMN1; SMN2MEN1MAPT
SCHEMBL21735571 0.81 CA2 (0.46) CA2SMN1; SMN2MAPTRAB9AMAPK1
SCHEMBL6832572 0.80 ESR1 (0.58) APPCA2SMN1; SMN2MEN1MAPT
SCHEMBL5682883 0.79 CYP1A1 (0.43) CA2SMN1; SMN2MEN1MAPTRAB9A
SCHEMBL226370 0.77 CA2 (0.50) APPCA2SMN1; SMN2MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0827959-B1 Benzo[B]thiophene compounds, intermediates, processes, compositions, and methods LILLY CO ELI (US) 2003-12-03 EP disclosed
US-5977382-A Benzo[b]thiophene compounds, intermediates, processes, compositions, and methods ELI LILLY AND COMPANY (US) 1999-11-02 US disclosed
US-5977098-A Benzo[B]thiophene compounds, intermediates, processes, compositions, and methods ELI LILLY AND COMPANY (US) 1999-11-02 US disclosed
US-5952513-A TREATING POSTMENOPAUSAL SYNDROME SUCH AS OSTEOPOROSIS ELI LILLY AND COMPANY (US) 1999-09-14 US disclosed
US-5843965-A Benzo B! thiophene compounds, intermediates, processes, compositions, and methods ELI LILLY AND COMPANY (US) 1998-12-01 US disclosed
EP-0827959-A2 Benzo[B]thiophene compounds, intermediates, processes, compositions, and methods ELI LILLY AND COMPANY (US) 1998-03-11 EP disclosed
US-5688796-A TREATING OSTEOPOROSIS, CARDIOVASCULAR DISORDERS, ESTROGEN-DEPENDENT CANCER, ENDOMETRIOSIS, SMOOTH MUSCLE CELL PROLIFERATION, RESTENOSIS ELI LILLY AND COMPANY (US) 1997-11-18 US disclosed
EP-0801066-A1 Heterocyclic substituted benzothiophenes and pharmaceutical compositions ELI LILLY AND COMPANY (US) 1997-10-15 EP disclosed